
Do you enjoy working with healthcare data and developing methods that bring societal value? Do you want to participate in research that can benefit patients around the world? Uppsala Monitoring Centre (UMC), a dynamic non-profit organisation with the mission to improve medicine safety globally, is opening a position for a 6-month internship or master thesis project starting September 2026 or later.
We have a project proposal in place, but you will be actively involved in shaping the project’s goals and determining the methods to be used.
Project: following up a signal identified in VigiBase using Swedish register data
Pharmacovigilance (PV) systems are a key component in drug safety monitoring, enabling early identification of potential adverse events related to medicines. Traditionally, the safety monitoring of approved medicines is relying on adverse event reporting systems that collect and analyse case report data to generate hypotheses on previously unknown or incompletely understood causal relationships between a medicine and an adverse event. These hypotheses are often referred to as “signals”. While adverse event reporting systems continue to inform most regulatory decisions, other evidence sources, including routine health data such as register-based records, are increasingly being used to support and enhance the analysis of signals.
The aim of this project is to follow up on a signal identified in VigiBase (the WHO global database of adverse event reports for medicines and vaccines, maintained by UMC) using pharmacoepidemiological analyses in Swedish register data, and to triangulate the results with insights from adverse event reports. The project involves analysis of Swedish register data using epidemiological study designs and descriptive analyses of case reports in VigiBase. Key activities include data cleaning, statistical analyses with advanced methods for causal effect estimation, and project documentation including literature review and manuscript writing.
Who you are:
Benefits for you:
The role requires working on-site at the Uppsala office.
Applications are considered on an ongoing basis during the application period.
#LI-DNI
Real-world impact – Working for the greater good
Learning organisation – Skilled and curious staff
Flexible work hours – Allows us to be at our best
Uppsala Monitoring Centre (UMC) is an independent, self-funded, non-profit foundation established in 1978 dedicated to safer use of medicines and vaccines. Through an agreement between the Government of Sweden and the World Health Organization (WHO), UMC operates the Programme for International Drug Monitoring, supporting over 180 member countries and regions in strengthening safety surveillance, and maintains VigiBase, the WHO global database of adverse event reports. In addition, UMC provides international standards and related digital solutions for secure exchange of pharmacovigilance data, including a global medicine and vaccine terminology for identification of medicinal products. With around 200 staff, UMC advances the science of pharmacovigilance and transforms its practice through technological innovation.
UMC’s working language is English. We normally apply a probationary period to new appointments.
If you have any questions regarding this position please contact the responsible manager. You will find the contact details at the end of this page.
UMC follows the collective agreements between the Swedish Agency for Government Employers and Saco-S and ST. Union representatives are Malin Zaar (Saco-S) and Jessica Avasol (ST), +46 (0)18-65 60 60.
Judith Brand | Contact Person